The landscape of global health is complex and constantly evolving, presenting immense challenges in resource allocation, ...

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...

Sam Peasah, PhD, MBA, RPh, director of High-Value Health Care Value-Based Pharmacy Initiatives at UPMC Health Plan, discusses ways that health plans can help reduce the cost burden of medications to ...

Recent budget cuts to organisations central to US and international health—for example, the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Disease ...

The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...

By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.

The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

The US Senate Judiciary Committee advanced to the full Senate six bills intended to reduce pharmaceutical prices and enhance ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.